Microwave -assisted Synthesis of Copper Nano particles: Influence nanoparticles morphology on the Cyto-toxic activity against triple negative Breast cancer

Prijzen vanaf
47,05

Uitgelicht

VERGELIJK ALLE AANBIEDERS (3)

Beschrijving

Bol The synthesis of metallic nanoparticles has emerged as a promising strategy for enhancing the therapeutic index and improving drug delivery efficiency in cancer treatment. Among various malignancies, breast cancer remains the most commonly diagnosed cancer among women worldwide. Although survival rates for breast cancer have significantly improved over the past three decades, the disease continues to exhibit considerable heterogeneity in its response to treatment modalities. Triple-negative breast cancer (TNBC) represents a particularly aggressive subtype characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expression. Due to the lack of these molecular targets, TNBC does not respond to hormone therapy or HER2-targeted treatments, making chemotherapy the primary therapeutic option. While TNBC may initially respond to chemotherapeutic agents, high rates of recurrence, metastasis, and associated mortality remain major clinical challenges.

Vergelijk aanbieders (3)

Shop
Prijs
Verzendkosten
Totale prijs
47,05
Gratis
47,05
Naar shop
Gratis Shipping Costs
47,15
Gratis
47,15
Naar shop
Gratis Shipping Costs
48,99
Gratis
48,99
Naar shop
Gratis Shipping Costs
Beschrijving (1)

The synthesis of metallic nanoparticles has emerged as a promising strategy for enhancing the therapeutic index and improving drug delivery efficiency in cancer treatment. Among various malignancies, breast cancer remains the most commonly diagnosed cancer among women worldwide. Although survival rates for breast cancer have significantly improved over the past three decades, the disease continues to exhibit considerable heterogeneity in its response to treatment modalities. Triple-negative breast cancer (TNBC) represents a particularly aggressive subtype characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expression. Due to the lack of these molecular targets, TNBC does not respond to hormone therapy or HER2-targeted treatments, making chemotherapy the primary therapeutic option. While TNBC may initially respond to chemotherapeutic agents, high rates of recurrence, metastasis, and associated mortality remain major clinical challenges.


Productspecificaties

Merk LAP LAMBERT Academic Publishing
EAN
  • 9786209935138
Maat


Prijshistorie

* Prijshistorie bevat geen data van Amazon, Amazon Marketplace.

Prijzen voor het laatst bijgewerkt op:

Uitgelichte Keuze
47,05
Naar shop